Evidence map›Paper›PMID 40515828›Full record

ArticleAnnals of hematology2025

Basophilia and eosinophilia in polycythemia vera and essential thrombocythemia: clinical, genotype, and prognostic correlates.

Priyansh Faldu, Muhammad Yousuf, Maymona Abdelmagid, Sarah Dingli, Kebede Begna, Cinthya J Zepeda Mendoza, Kaaren K Reichard, Rong He, Animesh Pardanani, Naseema Gangat and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Priyansh FalduDivision of Hematology, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
Muhammad YousufDivision of Hematology, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
Maymona AbdelmagidDivision of Hematology, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
Sarah DingliEarl E. Bakken Medical Devices Center, Department of Mechanical Engineering, University of Minnesota, Twin Cities, MN, USA.
Kebede BegnaDivision of Hematology, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
Cinthya J Zepeda MendozaDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Kaaren K ReichardDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Rong HeDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Animesh PardananiDivision of Hematology, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
Naseema GangatDivision of Hematology, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.
Ayalew TefferiDivision of Hematology, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. tefferi.ayalew@mayo.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current retrospective study evaluated clinical, genetic, and prognostic correlates of increased absolute basophil (ABC) and eosinophil (AEC) counts in polycythemia vera (PV; N = 475) and essential thrombocythemia (ET; N = 658). Median (range) ABC and AEC were 0.1 (0-3.2) and 0.3 (0-6.5) x 10

Indexed as

BasophilsEosinophiliaPolycythemia VeraThrombocythemia, EssentialAdultAgedAged, 80 and overFemaleGenotypeHumansJanus Kinase 2Leukocyte CountMaleMiddle AgedMutationPrognosisJAK2 protein, humanJanus Kinase 2BasophilEosinophilLeukemiaMyelofibrosisSurvival

Identifiers

PMID40515828
PMCPMC12283830

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.